Vig Pamela 4
4 · Mirum Pharmaceuticals, Inc. · Filed May 16, 2024
Insider Transaction Report
Form 4
Vig Pamela
Chief Scientific Officer
Transactions
- Award
Common Stock
2024-05-10$21.05/sh+94$1,978→ 27,406 total
Holdings
- 75,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This Form 4 is being filed voluntarily to report the acquisition of 94 shares by the Reporting Person on May 10, 2024 pursuant to the Issuer's Employee Stock Purchase Plan.